🇺🇸 Methylprednisolone, prednisone in United States

3 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 3

Most-reported reactions

1. Alanine Aminotransferase Increased — 1 report (33.33%)
2. Aspartate Aminotransferase Increased — 1 report (33.33%)
3. Transaminases Increased — 1 report (33.33%)

Source database →

Frequently asked questions

Is Methylprednisolone, prednisone approved in United States?

Methylprednisolone, prednisone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Methylprednisolone, prednisone in United States?

Medical University of Lodz is the originator. The local marketing authorisation holder may differ — check the official source linked above.